CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions		3 Months Ended		6 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Net Sales		$ 20,773	$ 20,953	$ 41,385	$ 41,291
Cost of Products Sold		10,897	10,664	21,743	21,029
Selling, General and Administrative Expense		5,091	5,121	9,918	10,071
Operating Income		4,785	5,168	9,724	10,191
Interest Expense		(171)	(106)	(294)	(215)
Interest Income		66	10	108	21
Other Non-operating Income/(Loss), Net		155	167	294	277
Earnings/(Loss) from Continuing Operations Before Income Taxes		4,835	5,239	9,832	10,274
Income Taxes on Continuing Operations		876	997	1,910	1,906
Net Earnings		3,959	4,242	7,922	8,368
Net Income (Loss) Attributable to Noncontrolling Interest		26	19	50	33
Net Income (Loss) Attributable to Parent		$ 3,933	$ 4,223	$ 7,872	$ 8,335
Basic Net Earnings Per Common Share
Basic Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.63	$ 1.72	$ 3.25	$ 3.39
Diluted Net Earnings Per Common Share
Diluted Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.59	$ 1.66	$ 3.16	$ 3.27
Diluted Weighted Average Common Shares Outstanding		2,481.2	2,544.2	2,492.4	2,551.6

[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.